NCT06245187 Get With the Guidelines Atrial Fibrillation Registry
| NCT ID | NCT06245187 |
| Status | Recruiting |
| Phase | — |
| Sponsor | American Heart Association |
| Condition | Atrial Fibrillation |
| Study Type | OBSERVATIONAL |
| Enrollment | 17,198 participants |
| Start Date | 2013-01 |
| Primary Completion | 2040-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 17,198 participants in total. It began in 2013-01 with a primary completion date of 2040-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.
Eligibility Criteria
Inclusion Criteria: * Patients hospitalized with nonvalvular Atrial Fibrillation or Atrial Flutter Exclusion Criteria: * Patients who do not have nonvalvular Atrial Fibrillation or Atrial Flutter * Patients under 18 years of age * Patients not admitted as inpatients. * Patients on comfort care only * Patients discharged to hospice.
Contact & Investigator
Javed Butler, MD
PRINCIPAL INVESTIGATOR
American Heart Association
Frequently Asked Questions
Who can join the NCT06245187 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 125 Years, studying Atrial Fibrillation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06245187 currently recruiting?
Yes, NCT06245187 is actively recruiting participants. Contact the research team at amy.bennett@heart.org for enrollment information.
Where is the NCT06245187 trial being conducted?
This trial is being conducted at Dallas, United States.
Who is sponsoring the NCT06245187 clinical trial?
NCT06245187 is sponsored by American Heart Association. The principal investigator is Javed Butler, MD at American Heart Association. The trial plans to enroll 17,198 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.